Compass opens U.S. grant program to build COMP360 provider training

Compass Pathways plc (CMPS) — Compass Pathways invited U.S. organizations to apply, from April 14 to May 14, for grants to develop healthcare-provider training for delivering COMP360 psilocybin therapy if approved.

The company expects to fund up to three organizations to build foundational psychedelic and COMP360-specific training modules. The move is part of Compass's commercial readiness effort ahead of a targeted end-of-2026 launch preparation for treatment-resistant depression.

Source: businesswire.com

For the rest of that week's sector news, read our week in review.